Merck & Co.

E106451

Merck & Co. is a major American pharmaceutical company known for developing and producing vaccines, oncology drugs, and other innovative medicines.

Try in SPARQL Jump to: Surface forms Statements Referenced by

All labels observed (9)

Statements (60)

Predicate Object
instanceOf multinational corporation
pharmaceutical company
public company
alternativeName Merck & Co.
surface form: Merck & Co., Inc.

Merck & Co.
surface form: Merck & Co., Inc., Rahway, NJ, USA
alternativeNameOutsideUSAndCanada MSD
brandName MSD
Merck & Co. self-linksurface differs
surface form: Merck Sharp & Dohme
businessModel research-based pharmaceutical company
CEO Robert M. Davis
chairperson Robert M. Davis
country United States of America
surface form: United States
focusArea animal health
cardiometabolic diseases
immunology
infectious diseases
oncology
vaccinology
formerHeadquartersLocation Kenilworth, New Jersey
surface form: Kenilworth, New Jersey, United States
foundedBy George Merck
hasDivision Animal Health
Human Health
Manufacturing
Research & Development
hasSubsidiary Merck & Co. self-linksurface differs
surface form: Merck Animal Health

Organon & Co. (historical, later spun off)
headquartersLocation Rahway, New Jersey
surface form: Rahway, New Jersey, United States
inception 1891
industry biotechnology
healthcare
pharmaceuticals
ISIN US58933Y1055
legalSeparationFromMerckKGaA World War I era
listedInIndex Dow Jones Industrial Average
S&P 500 Index
surface form: S&P 500
notableDrug Gardasil
Gardasil
surface form: Gardasil 9

Isentress
Januvia
Keytruda
Propecia
Singulair
Zetia
operatesInArea global
parentOrganizationHistory originated as the U.S. subsidiary of Merck KGaA
primaryProduct animal health products
antiviral drugs
cardiovascular drugs
diabetes treatments
oncology drugs
vaccines
R&DInvestmentFocus animal health products
biologic therapies
innovative prescription medicines
vaccines
researchDivision Merck & Co. self-linksurface differs
surface form: Merck Research Laboratories
spinoffDate 2021
spunOff Organon & Co. (historical, later spun off)
surface form: Organon & Co.
stockExchange New York Stock Exchange
tickerSymbol MRK

Referenced by (22)

Full triples — surface form annotated when it differs from this entity's canonical label.

Roy Vagelos employer Merck & Co.
Remicade isCoDevelopedBy Merck & Co.
rVSV-ZEBOV subsequentlyDevelopedBy Merck & Co.
Merck & Co. brandName Merck & Co. self-linksurface differs
this entity surface form: Merck Sharp & Dohme
Merck & Co. researchDivision Merck & Co. self-linksurface differs
this entity surface form: Merck Research Laboratories
Merck & Co. hasSubsidiary Merck & Co. self-linksurface differs
this entity surface form: Merck Animal Health
Merck & Co. alternativeName Merck & Co.
this entity surface form: Merck & Co., Inc.
Merck & Co. alternativeName Merck & Co.
this entity surface form: Merck & Co., Inc., Rahway, NJ, USA
Pfizer competitor Merck & Co.
Oss hasCompany Merck & Co.
this entity surface form: MSD (Merck Sharp & Dohme)
Decision to provide ivermectin (Mectizan) free of charge for river blindness madeBy Merck & Co.
this entity surface form: Merck Sharp & Dohme
Marie Merck familyName Merck & Co.
this entity surface form: Merck
Patricia Russo boardMemberOf Merck & Co.
Renflexis isMarketedBy Merck & Co.
Ervebo hasMarketingAuthorizationHolder Merck & Co.
this entity surface form: Merck Sharp & Dohme Corp.
Ervebo hasDeveloper Merck & Co.
NewLink Genetics collaboratedWith Merck & Co.